DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $506 | +3.5% | 2,039 | 0.0% | 0.11% | +10.1% |
| Q2 2023 | $489 | -5.4% | 2,039 | -0.5% | 0.10% | -10.0% |
| Q1 2023 | $517 | -2.8% | 2,050 | +2.2% | 0.11% | -6.8% |
| Q4 2022 | $532 | -99.9% | 2,005 | 0.0% | 0.12% | -13.9% |
| Q3 2022 | $518,000 | +2.0% | 2,005 | 0.0% | 0.14% | +7.9% |
| Q2 2022 | $508,000 | -13.6% | 2,005 | 0.0% | 0.13% | +2.4% |
| Q1 2022 | $588,000 | -14.2% | 2,005 | -3.7% | 0.12% | -8.1% |
| Q4 2021 | $685,000 | +6.9% | 2,081 | -1.1% | 0.14% | -1.5% |
| Q3 2021 | $641,000 | +13.5% | 2,105 | 0.0% | 0.14% | +17.1% |
| Q2 2021 | $565,000 | +1.4% | 2,105 | -14.9% | 0.12% | -6.4% |
| Q1 2021 | $557,000 | +1.3% | 2,475 | 0.0% | 0.12% | -8.1% |
| Q4 2020 | $550,000 | +3.0% | 2,475 | -0.3% | 0.14% | -9.9% |
| Q3 2020 | $534,000 | +21.6% | 2,482 | 0.0% | 0.15% | +15.3% |
| Q2 2020 | $439,000 | +28.0% | 2,482 | +0.3% | 0.13% | +8.3% |
| Q1 2020 | $343,000 | -9.7% | 2,475 | 0.0% | 0.12% | +19.8% |
| Q4 2019 | $380,000 | +6.4% | 2,475 | 0.0% | 0.10% | +2.0% |
| Q3 2019 | $357,000 | -0.6% | 2,475 | -1.4% | 0.10% | -2.9% |
| Q2 2019 | $359,000 | +8.5% | 2,510 | 0.0% | 0.10% | +3.0% |
| Q1 2019 | $331,000 | +27.8% | 2,510 | 0.0% | 0.10% | +8.8% |
| Q4 2018 | $259,000 | -5.1% | 2,510 | 0.0% | 0.09% | +28.2% |
| Q3 2018 | $273,000 | -44.7% | 2,510 | -50.0% | 0.07% | +2.9% |
| Q2 2018 | $494,000 | +100.8% | 5,020 | +100.0% | 0.07% | -1.4% |
| Q1 2018 | $246,000 | +5.6% | 2,510 | 0.0% | 0.07% | +9.4% |
| Q4 2017 | $233,000 | +7.4% | 2,510 | -0.8% | 0.06% | +4.9% |
| Q3 2017 | $217,000 | +1.9% | 2,529 | 0.0% | 0.06% | 0.0% |
| Q2 2017 | $213,000 | -1.4% | 2,529 | 0.0% | 0.06% | -3.2% |
| Q1 2017 | $216,000 | -15.0% | 2,529 | +0.8% | 0.06% | +61.5% |
| Q3 2016 | $254,000 | 0.0% | 2,510 | 0.0% | 0.04% | -50.6% |
| Q2 2016 | $254,000 | +6.7% | 2,510 | 0.0% | 0.08% | +5.3% |
| Q1 2016 | $238,000 | +2.1% | 2,510 | 0.0% | 0.08% | -1.3% |
| Q4 2015 | $233,000 | +6.9% | 2,510 | -1.8% | 0.08% | +1.3% |
| Q3 2015 | $218,000 | -0.5% | 2,555 | 0.0% | 0.08% | +4.2% |
| Q2 2015 | $219,000 | +0.9% | 2,555 | 0.0% | 0.07% | -4.0% |
| Q1 2015 | $217,000 | -0.9% | 2,555 | 0.0% | 0.08% | -5.1% |
| Q4 2014 | $219,000 | +9.0% | 2,555 | 0.0% | 0.08% | +3.9% |
| Q2 2014 | $201,000 | – | 2,555 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |